Also trades as: NXG.V (TSXV) · $vol 0M
NEGXF OTC
NexgenRx Inc.
1W: -2.8%
1M: +37.5%
3M: +35.4%
YTD: +57.1%
1Y: +120.0%
3Y: +131.1%
5Y: +242.6%
$0.44
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$1M
-10.0% ▼
Capital Expenditures
$318K
-27.9% ▼
5Y CAGR: -20.2%
Free Cash Flow
$833K
-19.1% ▼
Dividends Paid
$908K
-0.6% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$171K
-255.7% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $2M | $4M | -$22K | -$332K | $615K |
| Depreciation & Amort. | $939K | $1M | $1M | $1M | $1M |
| Stock-Based Comp. | $102K | $132K | $83K | $36K | $15K |
| Change in Working Capital | -$4M | -$409K | $2M | $229K | -$1M |
| Other Non-Cash Items | $85K | -$62K | $5K | $26K | $29K |
| Operating Cash Flow | -$921K | $3M | $3M | $1M | $1M |
| — Investing Activities — | |||||
| Capital Expenditures | -$1M | -$1M | -$502K | -$77K | -$86K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | -$181K |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$960K | -$1M | -$117K | -$171K | -$232K |
| Investing Cash Flow | -$1M | -$1M | -$502K | -$248K | -$498K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$1M | -$809K | -$208K | -$79K | -$102K |
| Stock Repurchased | $1 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$65K | -$131K | -$893K | -$902K | -$908K |
| Other Financing | $0 | -$35K | -$318K | $0 | $0 |
| Financing Cash Flow | -$1M | -$947K | -$1M | -$919K | -$823K |
| Net Change in Cash | $4M | $2M | -$4M | $110K | -$171K |
| Cash End of Period | $18M | $20M | $17M | $2M | $2M |
| Free Cash Flow | -$2M | $2M | $3M | $1M | $833K |